AngioDynamics ANGO has been gaining from its solid prospects with NanoKnife and an increased focus on cancer treatment markets. The optimism, led by a solid fourth-quarter fiscal 2025 performance, ...

BEIJING, Aug. 21, 2025 (GLOBE NEWSWIRE) -- (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the ...

“With more than 200,000 patients treated globally and the broadest label of any BTK inhibitor in Europe, BRUKINSA's differentiated clinical profile continues to make an impact for people facing ...

Can BTK inhibitors finally move the needle in progressive MS? Dr Robert Fox joins Dr Anne Cross to unpack the results of the ...

Air Canada has resumed operations but it will be days before the backlog of flight cancellations are cleared. Many passengers ...

WICHITA, Kan. (KWCH) - On August 18, 2005, 20 years ago, a Sedgwick County judge sentenced Dennis Rader, also known as the ...

Pakistan has seen higher-than-normal monsoon rains since June 26 that have killed at least 645 people across the country, ...

The professor who once taught Bryan Kohberger is still haunted by his crimes and wants answers the court never uncovered.

CLL-314 trial compared the efficacy and safety of pirtobrutinib with ibrutinib in adults with CLL/SLL who were treatment-naïve or who were previously treated and were BTK inhibitor-naïve.

Panelists discuss how providers and payers must collaborate to develop innovative coverage criteria for BTK inhibitors that ...